| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and lowers the price target from $92 to $90.
																	
																	Citigroup analyst Filippo Falorni maintains Colgate-Palmolive (NYSE:CL) with a Buy and lowers the price target from $105 to ...
																	Morgan Stanley analyst Dara Mohsenian maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target fr...
																	JP Morgan analyst Andrea Teixeira maintains Colgate-Palmolive (NYSE:CL) with a Overweight and lowers the price target from $...
																	Evercore ISI Group analyst Robert Ottenstein maintains Colgate-Palmolive (NYSE:CL) with a Outperform and lowers the price ta...
																	Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:CL) with a Underweight and lowers the price target from $8...
																	Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap gi...
																	CL shares are down after reporting Q3 results, but expect growth thanks to new strategy and strong market share. Keep an eye on...